BLPH logo

Bellerophon Therapeutics Inc

BLPH

$0.05

Key details

CEO

Fabian Tenenbaum

Employees

27

Headquarters

Warren, US

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

About Bellerophon Therapeutics Inc

bellerophon therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need.

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG